Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Raffeld

Showing results (181-190 of 276) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|July 9, 2009
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, et al.
Blood|August 7, 2019
Recurrent somatic <i>JAK3</i> mutations in NK-cell enteropathyWenbin Xiao, Gaurav K Gupta, Jinjuan Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancerMonica Brown Jones, Chad M Michener, James O Blanchette, et al.
Frontiers in Endocrinology|March 6, 2020
A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort StudyCristiane J Gomes-Lima, Sungyoung Auh, Shilpa Thakur, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
The American Journal of Surgical Pathology|November 26, 2019
Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic PitfallCaoimhe Egan, Camille Laurent, Julie C Alejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2016
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphomaKamal Sharma, John E Janik, Deirdre O'Mahony, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Pageof 28

Showing results (181-190 of 276) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|July 9, 2009
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibitionAnnamaria Rapisarda, Melinda Hollingshead, Badarch Uranchimeg, et al.
Blood|August 7, 2019
Recurrent somatic <i>JAK3</i> mutations in NK-cell enteropathyWenbin Xiao, Gaurav K Gupta, Jinjuan Yao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancerMonica Brown Jones, Chad M Michener, James O Blanchette, et al.
Frontiers in Endocrinology|March 6, 2020
A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort StudyCristiane J Gomes-Lima, Sungyoung Auh, Shilpa Thakur, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Blood Advances|August 8, 2019
Clonal expansion of CAR T cells harboring lentivector integration in the CBL gene following anti-CD22 CAR T-cell therapyNirali N Shah, Haiying Qin, Bonnie Yates, et al.
The American Journal of Surgical Pathology|November 26, 2019
Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic PitfallCaoimhe Egan, Camille Laurent, Julie C Alejo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2016
Phase II Study of Alemtuzumab (CAMPATH-1) in Patients with HTLV-1-Associated Adult T-cell Leukemia/lymphomaKamal Sharma, John E Janik, Deirdre O'Mahony, et al.
Blood|July 30, 2010
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N Kochenderfer, Wyndham H Wilson, John E Janik, et al.
Leukemia & Lymphoma|July 16, 2005
Validation of tissue microarray immunohistochemistry staining and interpretation in diffuse large B-cell lymphomaYouli Zu, Seth M Steinberg, Elias Campo, et al.
Pageof 28